{"id":"W2794378246","doi":"10.2147/dddt.s130809","title":"Rucaparib: a novel PARP inhibitor for <em>BRCA</em> advanced ovarian cancer","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Cancer research; Medicine; Poly ADP ribose polymerase; Chemistry; Pharmacology; Cancer; Internal medicine; Biochemistry; DNA; Polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001428925,0.0005214514,0.0005418001,0.00041183,0.0001892607,0.0003801979,0.0006595445,0.0005671192,0.004943781],"category_scores_gemma":[0.0001191577,0.0001369269,0.0002945483,0.000450736,0.0002070452,0.0002674433,0.000236828,0.001254634,0.001739373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003958008,"about_ca_system_score_gemma":0.0003452024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006002886,"about_ca_topic_score_gemma":0.0008523474,"domain_scores_codex":[0.999925,0.00001268718,0.00000616842,0.00001844804,0.00001883807,0.00001882483],"domain_scores_gemma":[0.9999491,0.00000431899,0.000009087587,0.000004620975,0.000008853815,0.00002412105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008052686,0.003288453,0.002773124,0.002063042,0.0002894607,0.002351026,0.0001001497,0.002602656,0.3493757,0.002013074,0.04424315,0.5828476],"study_design_scores_gemma":[0.01692169,0.03378657,0.02966022,0.0003863281,0.0006973423,0.02522249,0.00008206494,0.01448591,0.4339208,0.0008938927,0.4437669,0.0001757815],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7201114,0.2019697,0.01415837,0.002846227,0.001324357,0.001287542,0.005555953,0.00329602,0.04945048],"genre_scores_gemma":[0.9356578,0.02771123,0.006185785,0.001800976,0.0003009339,0.0005168853,0.008957651,0.00008838646,0.01878035],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.004943781,"threshold_uncertainty_score":0.01653862,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1120232755198394,"score_gpt":0.3535853993551428,"score_spread":0.2415621238353035,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}